Posted on

Black Kite FocusTags allows users to track high-profile cyber events – Help Net Security

Black Kite FocusTags allows users to track high-profile cyber events - Help Net Security

Black Kite released FocusTags, helping users to track high-profile cyber events and identify which vendors have been affected within their supply chain.

Black Kite FocusTags

This latest capability furthers the company’s mission to provide continuous monitoring of vendors to identify and mitigate ransomware and other risks. FocusTags are automatically applied following high-profile cyberattacks but can also be added to help with supply chain organization.

“Time is of the essence when a cyber event disrupts the digital supply chain. You need immediate visibility into what happened and which of your vendors are at risk so you can take action,” said Chris Bush, CCO of Black Kite. “Our FocusTags give users the speed, clarity and visibility they need to manage incidents at scale and protect their bottom-line.”

Examples of incidents that trigger FocusTags include known ransomware attacks (such as those by Conti, Clop and REvil), data breaches (such as Lapsus$), geopolitical events that affect vendors in conflicted areas (such as the current war in Ukraine) and violations of the National Defense Authorization Act 2019 Section 889.

Black Kite FocusTags can also be used to filter vendor ecosystems. For example, a custom tag can be added to identify critical vendors who hold a large amount of PII or to indicate vendors that may have internal systems access.

“Our clients need continuous monitoring so they can ensure the safety and reliability of their supply chains. Point-in-time monitoring is simply not an effective strategy for combating the complexity of cyber incidents today,” said Chuck Schauber, VP of Product Strategy for Black Kite. “FocusTags makes it easy to see, organize and collaborate with vendors at scale.”

Black Kite provides technical, financial, and compliance-related third-party cyber risk intelligence. The technology eliminates false positives and ensures a holistic approach to vendor risk management.

Black Kite FocusTags are available now.

Posted on

Clopidogrel monotherapy linked with reduced risk of net adverse clinical events, study finds

Clopidogrel monotherapy linked with reduced risk of net adverse clinical events, study finds

Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin monotherapy beyond 12 months after PCI in high-risk patients during the chronic maintenance period. This study found that clopidogrel monotherapy was associated with reduced risk of net adverse clinical events (NACE; all-cause death, MI, stent thrombosis, stroke, or BARC type 2, 3, or 5 bleeding) and MACCE (death, MI, stent thrombosis, stroke), and a numerical decrease in major or clinically relevant nonmajor bleeding (BARC type 2, 3, or 5 bleeding), compared with aspirin monotherapy. The findings were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.

P2Y12 inhibitor monotherapy reduces bleeding risk without increasing the risk of ischemic events compared with dual antiplatelet therapy (DAPT), especially in the first 12 months following percutaneous coronary intervention (PCI). Recent research showed that among patients who were event free for six to 18 months post-PCI and successfully received the intended duration of DAPT, clopidogrel monotherapy was superior compared with aspirin monotherapy in terms of NACE. However, optimal antiplatelet monotherapy during the chronic maintenance period beyond 12 months after PCI with drug-eluting stents in high-risk patients in real-world settings is previously unknown.

In total, 8,377 consecutive patients at high risk for both bleeding and thrombosis were identified from the prospective Fuwai PCI Registry if they satisfied one clinical and one angiographic criterion. Patients who received antiplatelet (aspirin or clopidogrel) monotherapy longer than 12 months and were free from ischemic and bleeding events at 12-month post-PCI without extended duration of DAPT were included. The primary endpoint was net adverse clinical events (NACE) from 12 to 30 months. The key secondary endpoints were major adverse cardiac or cerebral events (MACCE) and major or clinically relevant nonmajor bleeding (BARC type 2, 3 or 5).

“These findings show for the first time clopidogrel monotherapy is associated with reduced risk of long-term NACE and MACCE,” said Hao-Yu Wang, Cardiometabolic Medicine Center, Coronary Heart Disease Center, Department of Cardiology, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. “Our results may have important practical implications for determining the optimal treatment for patients requiring a single antiplatelet drug, either aspirin or clopidogrel, for secondary prevention of ischemic events in high-risk PCI population.”

Of 7,392 high-risk patients that were event-free after the first year and adherent to DAPT, 5,664 patients who received antiplatelet monotherapy (clopidogrel monotherapy: n=1,974 and aspirin monotherapy: n=3690) were included in the present analysis. Researchers found that between 12 and 30 months, the net adverse clinical events were lower with clopidogrel monotherapy compared to aspirin monotherapy (Kaplan-Meier estimate: 2.5% vs. 5.0%; adjusted HR:0.566, 95% CI: 0.403-0.795). Clopidogrel monotherapy was associated with lower risk for MACCE (Kaplan-Meier estimate: 1.0% vs. 3.1%, log-rank p = 0.001 ), as well as lower incidence rates of all-cause death, MI, and stroke. The difference in risk between the groups was statistically similar for major or clinically relevant nonmajor bleeding (Kaplan-Meier estimate: 1.5% vs. 2.1%, log-rank p = 0.199).

Researchers recommended that their findings should be further investigated through a randomized clinical trial.

Posted on

Ermetic launches open source tool that analyzes AWS CloudTrail AccessDenied events – Help Net Security

Ermetic launches open source tool that analyzes AWS CloudTrail AccessDenied events - Help Net Security

Ermetic released a free open source tool for managing AccessDenied Events in Amazon Web Services (AWS) that automates time consuming cloud access policy troubleshooting and correction.

Ermetic Access Undenied on AWS

Access Undenied on AWS analyzes AWS CloudTrail AccessDenied events, scans the environment to identify and explain the reasons for the events, and offers actionable least-privilege remediation suggestions.

The project is led by Noam Daham, research lead at Ermetic.

“Even if you know the policy type causing ‘access denied’, which isn’t always the case, you still need to find the policy and the statement inside the policy causing the denial, and replace it with a least-privilege alternative,” Noam Dahan. “Basically, you give the Access Undenied on AWS tool a CloudTrail event with an “Access Denied” outcome, and it will tell you how to fix it!”

Access Undenied on AWS addresses some of the peskiest Access Denied challenges encountered by DevOps and security teams on a daily basis, including:

  • Some AccessDenied messages still do not provide details. Among the services for which some, or even many, messages are lacking in detail are: S3, IAM, STS, CloudWatch, EFS, DynamoDB, Redshift, Opensearch and ACM.
  • When the reason for AccessDenied is an explicit deny, users can have difficulty tracking down the specific policy and statement that generated the explicit deny. Specifically, when the reason is an explicit deny in a service control policy (SCP), it is difficult to find and assess every single policy in the organization that applies to the account.
  • Meanwhile, when the problem is a missing allow statement, it can still be challenging to create the least-privilege policy that allows the desired access without granting excessive permissions.

Access Undenied on AWS is available now and supports policies for many resources and some of the most common condition keys. This open source project is also soliciting input from the community through contributions of new issues in the repository.

Posted on

Who is Michael Buffer? Major events, net worth of boxing announcer

Who is Michael Buffer? Major events, net worth of boxing announcer

“Let’s get ready to rumble.”

Those words have become synonymous with boxing events, as has the voice and creator of that catchphrase, Michael Buffer.

Buffer has been a ring announcer since the 1980s. During that time, he has been ringside for a number of major sporting events like boxing matches, Stanley Cup playoff games, World Series games, Indy 500 races and many more.

But there’s been one event Buffer has said he’s always wanted to call: the Super Bowl.

“A Super Bowl would be great,” Buffer told Sports Illustrated.

Buffer announced the start of the Rams’ wild-card matchup against the Cardinals. He then kicked off the NFC Championship for Los Angeles against the 49ers. Could this year’s game be next?

“I think it’s all decided what’s going to happen right down to every split second,” Buffer told SI.


Super Bowl 2022 halftime show, explained: How Jay-Z staged a star-studded lineup fit for L.A.

Michael Buffer’s major events

Buffer has primarily deployed his catchphrase and iconic voice at boxing matches. He began his announcing career in the early 1980s, and quickly became the announcer for Top Rank events. By the late 1980s, he was the primary announcer at casinos owned by Donald Trump.

Buffer has announced fights featuring some of the sport’s most prominent boxers, including Sugar Ray Leonard, Evander Holyfield, Floyd Mayweather and Canelo Alvarez. Buffer has been the ring announcer for DAZN fights since 2018, and has previously had deals with HBO and NBC Sports Network.

But Buffer has also announced the start of several major sporting events. He was an announcer for the 1999 Indianapolis 500, 2017 NBA Finals, 2017 United States Grand Prix, the 2018 Stanley Cup Finals and 2019 National League Championship Series, among others.

He has also made appearances on “Saturday Night Live,” “American Idol” and “Deal or No Deal.”


How much do NFL players make for winning Super Bowl?

Michael Buffer net worth

According to Celebrity Net Worth, Buffer has a net worth of $400 million. It says that he makes between $25,000 and $100,000 per fight, though occasionally he has made up to $1 million.

The majority of his career earnings have actually come from a trademark on his catchphrase. ABC News reported that his trademark has earned him more than $400 million in revenue by selling it to music, video games and merchandise.